Australia markets closed

Amplia Therapeutics Limited (ATX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0650+0.0010 (+1.56%)
At close: 10:35AM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Operating expenses
Research development
3,352
4,687
3,772
2,212
Selling general and administrative
2,595
2,408
1,697
1,349
Total operating expenses
6,406
7,475
5,627
3,874
Operating income or loss
-6,406
-7,475
-5,627
-3,874
Interest expense
84.337
53.848
1.15
-
Total other income/expenses net
1,869
1,189
1,983
1,591
Income before tax
-4,460
-6,242
-3,644
-2,281
Income tax expense
0
0
0
0
Income from continuing operations
-4,460
-6,242
-3,644
-2,281
Net income
-4,460
-6,242
-3,644
-2,281
Net income available to common shareholders
-4,460
-6,242
-3,644
-2,281
Basic EPS
-0.02
-0.03
-0.03
-0.02
Diluted EPS
-0.02
-0.03
-0.03
-0.02
Basic average shares
194,006
193,975
145,549
95,700
Diluted average shares
194,006
193,975
145,549
95,700